Central nervous system histoplasmosis in acquired immunodeficiency syndrome

Harita Nyalakonda, Marisol Albuerne, Lia Patricia Suazo Hernandez, Juan Sarria

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Involvement of the central nervous system (CNS) by Histoplasma capsulatum in AIDS is uncommon and not easily recognized. Materials and Methods: CNS histoplasmosis cases from our institution were identified by a retrospective chart review from 2004-2014. A thorough literature search was performed for additional cases and their characteristics were compared. Clinical findings, treatment and outcomes are discussed. Results: A total of 5 cases from our institution were identified. They had a clinical presentation that included classic signs of meningitis, often with evidence of disseminated involvement, and was typically severe with important neurological impairment. These cases were treated with antifungal agents, including a lipid amphotericin B formulation and azole drugs, but eventually 3 experienced nonresolution of their disease likely because of lack of adherence to therapy and died from their infection. The clinical presentation, treatment and outcome of these cases did not significantly differ from cases found in the review of the literature. Conclusions: Clinicians practicing in endemic areas should be aware of this rare but serious form of histoplasmosis. The recognition of 5 cases of CNS histoplasmosis in AIDS patients from a single institution suggests that histoplasmosis should be included in the differential diagnosis of the CNS complications of AIDS.

Original languageEnglish (US)
Pages (from-to)177-186
Number of pages10
JournalAmerican Journal of the Medical Sciences
Volume351
Issue number2
DOIs
StatePublished - 2016

Fingerprint

Histoplasmosis
Acquired Immunodeficiency Syndrome
Central Nervous System
Histoplasma
Azoles
Drug Compounding
Antifungal Agents
Amphotericin B
Meningitis
Differential Diagnosis
Lipids
Infection
Therapeutics

Keywords

  • AIDS
  • Central nervous system
  • Histoplasma capsulatum
  • Histoplasmosis
  • HIV

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Central nervous system histoplasmosis in acquired immunodeficiency syndrome. / Nyalakonda, Harita; Albuerne, Marisol; Hernandez, Lia Patricia Suazo; Sarria, Juan.

In: American Journal of the Medical Sciences, Vol. 351, No. 2, 2016, p. 177-186.

Research output: Contribution to journalArticle

Nyalakonda, Harita ; Albuerne, Marisol ; Hernandez, Lia Patricia Suazo ; Sarria, Juan. / Central nervous system histoplasmosis in acquired immunodeficiency syndrome. In: American Journal of the Medical Sciences. 2016 ; Vol. 351, No. 2. pp. 177-186.
@article{7ec4dbddb6f5449e9dbe462c227cdfc3,
title = "Central nervous system histoplasmosis in acquired immunodeficiency syndrome",
abstract = "Background: Involvement of the central nervous system (CNS) by Histoplasma capsulatum in AIDS is uncommon and not easily recognized. Materials and Methods: CNS histoplasmosis cases from our institution were identified by a retrospective chart review from 2004-2014. A thorough literature search was performed for additional cases and their characteristics were compared. Clinical findings, treatment and outcomes are discussed. Results: A total of 5 cases from our institution were identified. They had a clinical presentation that included classic signs of meningitis, often with evidence of disseminated involvement, and was typically severe with important neurological impairment. These cases were treated with antifungal agents, including a lipid amphotericin B formulation and azole drugs, but eventually 3 experienced nonresolution of their disease likely because of lack of adherence to therapy and died from their infection. The clinical presentation, treatment and outcome of these cases did not significantly differ from cases found in the review of the literature. Conclusions: Clinicians practicing in endemic areas should be aware of this rare but serious form of histoplasmosis. The recognition of 5 cases of CNS histoplasmosis in AIDS patients from a single institution suggests that histoplasmosis should be included in the differential diagnosis of the CNS complications of AIDS.",
keywords = "AIDS, Central nervous system, Histoplasma capsulatum, Histoplasmosis, HIV",
author = "Harita Nyalakonda and Marisol Albuerne and Hernandez, {Lia Patricia Suazo} and Juan Sarria",
year = "2016",
doi = "10.1016/j.amjms.2015.11.016",
language = "English (US)",
volume = "351",
pages = "177--186",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Central nervous system histoplasmosis in acquired immunodeficiency syndrome

AU - Nyalakonda, Harita

AU - Albuerne, Marisol

AU - Hernandez, Lia Patricia Suazo

AU - Sarria, Juan

PY - 2016

Y1 - 2016

N2 - Background: Involvement of the central nervous system (CNS) by Histoplasma capsulatum in AIDS is uncommon and not easily recognized. Materials and Methods: CNS histoplasmosis cases from our institution were identified by a retrospective chart review from 2004-2014. A thorough literature search was performed for additional cases and their characteristics were compared. Clinical findings, treatment and outcomes are discussed. Results: A total of 5 cases from our institution were identified. They had a clinical presentation that included classic signs of meningitis, often with evidence of disseminated involvement, and was typically severe with important neurological impairment. These cases were treated with antifungal agents, including a lipid amphotericin B formulation and azole drugs, but eventually 3 experienced nonresolution of their disease likely because of lack of adherence to therapy and died from their infection. The clinical presentation, treatment and outcome of these cases did not significantly differ from cases found in the review of the literature. Conclusions: Clinicians practicing in endemic areas should be aware of this rare but serious form of histoplasmosis. The recognition of 5 cases of CNS histoplasmosis in AIDS patients from a single institution suggests that histoplasmosis should be included in the differential diagnosis of the CNS complications of AIDS.

AB - Background: Involvement of the central nervous system (CNS) by Histoplasma capsulatum in AIDS is uncommon and not easily recognized. Materials and Methods: CNS histoplasmosis cases from our institution were identified by a retrospective chart review from 2004-2014. A thorough literature search was performed for additional cases and their characteristics were compared. Clinical findings, treatment and outcomes are discussed. Results: A total of 5 cases from our institution were identified. They had a clinical presentation that included classic signs of meningitis, often with evidence of disseminated involvement, and was typically severe with important neurological impairment. These cases were treated with antifungal agents, including a lipid amphotericin B formulation and azole drugs, but eventually 3 experienced nonresolution of their disease likely because of lack of adherence to therapy and died from their infection. The clinical presentation, treatment and outcome of these cases did not significantly differ from cases found in the review of the literature. Conclusions: Clinicians practicing in endemic areas should be aware of this rare but serious form of histoplasmosis. The recognition of 5 cases of CNS histoplasmosis in AIDS patients from a single institution suggests that histoplasmosis should be included in the differential diagnosis of the CNS complications of AIDS.

KW - AIDS

KW - Central nervous system

KW - Histoplasma capsulatum

KW - Histoplasmosis

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=84960908456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960908456&partnerID=8YFLogxK

U2 - 10.1016/j.amjms.2015.11.016

DO - 10.1016/j.amjms.2015.11.016

M3 - Article

VL - 351

SP - 177

EP - 186

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 2

ER -